orphazyme as a small danish biotech firm that morphed into a meme stock last week was dumped by investors on friday after it failed to get a clear stamp of approval from us authorities for its only viable treatment the company’s american depositary shares lost almost half their value once trading started in the us matching a selloff in copenhagen earlier in the day the move brings its market cap to about 300 million compared with 560 million less than 24 hours ago